ImmunityBio, Inc. (IBRX)

NasdaqGS • Currently up 0.11 (+1.12%) in today's trading session

1 member of Congress has disclosed 2 trades in ImmunityBio, Inc. (IBRX) via STOCK Act filings. The most recent disclosure was a purchase by Lisa McClain on 30 September 2026. Aggregate disclosed activity totals roughly $16K in purchases (midpoint estimates from bracketed disclosure amounts).

ImmunityBio, Inc. is currently trading at $9.91, positioned at 76% of its 52-week range ($1.95 – $12.43).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$9.91
24h Change
+0.11 (+1.12%)
52 Week Range
$1.95–$12.43
View on NASDAQ

ImmunityBio, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for IBRX

Select to highlight on chart
2 transactions
Compliance: 100%
Lisa McClain30 Sept 202612 Oct 2026PurchaseStock$1,001 - $15,000+12.23%
Lisa McClain28 Sept 202612 Oct 2026PurchaseStock$1,001 - $15,000+16.31%

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$10.5B

Volume

30.07M

Beta

0.13

P/E Ratio

-10.22

Fundamentals

EPS

$-0.97

Div. Yield

-

Open

$9.69

Day Range

$9.35 – $10.46

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Richard Gerald Adcock
IPO Date
2015-07-28
Website
immunitybio.com

ImmunityBio, Inc. is a clinical-stage biotechnology firm, founded in 2014 and based in San Diego, California. The company is focused on developing groundbreaking therapies and vaccines designed to treat a wide array of cancers and infectious diseases...

Earnings

Next Report

Q3 2026

3 Nov

EPS Est.

$-0.07

Rev. Est.

$59.2M

Days Until

19

Recent Quarters

Q2 20264 Aug
EPS$-0.22
Miss 175.0%
Q1 20267 May
EPS$-0.62
Miss 675.0%
Q4 202523 Feb
EPS$-0.06
Beat 25.0%
Q3 20254 Nov
EPS$-0.07
Beat 30.0%
Q2 20255 Aug
EPS$-0.10
Beat 0.0%
Q1 202512 May
EPS$-0.15
Miss 25.0%
Q4 20243 Mar
EPS$-0.09
Beat 65.4%
Q3 202412 Nov
EPS$-0.14
Beat 22.2%
Q2 202412 Aug
EPS$-0.20
Miss 17.6%
Q1 20249 May
EPS$-0.20
Miss 25.0%
Q4 202319 Mar
EPS$-0.36
Miss 100.0%
Q3 20238 Nov
EPS$-0.19
Beat 29.6%
Q2 20238 Aug
EPS$-0.28
Miss 7.7%
Q1 202311 May
EPS$-0.27
Beat 0.0%
Q4 20221 Mar
EPS$-0.27
Miss 22.7%
Q3 20229 Nov
EPS$-0.28
Miss 21.7%
Q2 20228 Aug
EPS$-0.24
Beat 0.0%
Q1 202210 May
EPS$-0.26
Miss 18.2%
Q4 20212 Mar
EPS$-0.23
Miss 9.5%
Q3 202130 Dec
EPS$-0.22
Miss 10.0%
Q2 202112 Aug
EPS$-0.23
Miss 91.7%
Q1 202114 May
EPS$-0.21
Beat 48.8%
Q4 20204 Mar
EPS$-0.30
Miss 66.7%
Q3 20209 Nov
EPS$-0.20
Miss 11.1%
Q2 20207 Aug
EPS$-0.20
Miss 5.3%
Q1 202011 May
EPS$-0.19
Miss 11.8%
Q4 201925 Mar
EPS$-0.16
Beat 20.0%
Q3 20195 Nov
EPS$-0.16
Beat 11.1%
Q2 20196 Aug
EPS$-0.17
Beat 29.2%
Q1 20198 May
EPS$-0.22
Beat 4.3%
Q4 201813 Mar
EPS$-0.22
Beat 29.0%
Q3 20187 Nov
EPS$-0.30
Beat 18.9%
Q2 20186 Aug
EPS$-0.35
Beat 7.9%
Q1 20187 May
EPS$-0.35
Miss 2.9%
Q4 201712 Mar
EPS$-0.31
Beat 6.1%
Q3 20177 Nov
EPS$-0.30
Beat 6.3%
Q2 20177 Aug
EPS$-0.29
Beat 6.5%
Q1 20178 May
EPS$-0.30
Beat 16.7%
Q4 201615 Mar
EPS$-0.29
Beat 32.6%
Q3 201610 Nov
EPS$-0.39
Beat 13.3%
Q2 201615 Aug
EPS$-0.41
Beat 29.3%
Q1 201616 May
EPS$-0.38
Miss 2.7%
Q4 201530 Mar
EPS$-0.97
Miss 321.7%
Q3 201512 Nov
EPS$-0.55
Miss 450.0%
Q2 201510 Sept
EPS$-1.29
Miss 892.3%
Q2 201531 Jul
EPS-

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

PLTR

Palantir Technologies Inc.

22
$200.97-7.70 (-3.69%)
Technology
Held by same politician
Significant holdings value
1 politician
View Stock

TSM

Taiwan Semiconductor Manufacturing Company Limited

20
$430.00-15.12 (-3.40%)
Technology
Held by same politician
Significant holdings value
1 politician
View Stock

NVDA

NVIDIA Corporation

20
$221.30-7.22 (-3.16%)
Technology
Held by same politician
Significant holdings value
1 politician
View Stock

Frequently Asked Questions about IBRX

Which members of Congress have traded IBRX?
1 member of Congress has disclosed 2 trade in ImmunityBio, Inc. (IBRX) under the STOCK Act: Lisa McClain.
When was IBRX most recently disclosed by Congress?
The most recent IBRX disclosure was a purchase by Lisa McClain on 30 September 2026.
What is the total disclosed congressional trading volume for IBRX?
Members of Congress have disclosed approximately $16K in IBRX purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in IBRX?
This IBRX page updates as soon as new STOCK Act disclosures are filed for ImmunityBio, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.